Started: 3/2020
Study name: A phase 3, randomized, double- or observer-blinded, placebo-controlled trial to evaluate the efficacy and safety of a respiratory syncytial virus (rsv) perfusion subunit vaccine in infants born to women vaccinated during pregnancy
Indication: RSV/OB
Principal Investigator: Brad Brabec
COVID-19 and Flu Swab Test Study Contact our Research Coordinator to ask
Phase III Study of live-attenuated respiratory syncytial virus (RSV) vaccine in healthy
Measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children
24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Health Infants Given 4 Doses at
